<DOC>
	<DOC>NCT01475708</DOC>
	<brief_summary>The investigators will compare the outcome of three groups of erythema migrans patients treated with doxycycline: a group without any accompanying symptoms, with mild symptoms and with severe symptoms that require lumbar puncture.</brief_summary>
	<brief_title>Doxycycline in Therapy of Erythema Migrans</brief_title>
	<detailed_description>Patients with erythema migrans treated with doxycycline for two weeks will be followed-up for one year (at 2 weeks, 2, 6 and 12 months) clinically and also by filling in the questionnaire to assess the presence of certain symptoms. Also the control group of their friends or relatives without a history of Lyme borreliosis will be included. The presence of their (unspecific) symptoms will also be recorded by the questionnaire at the time of enrollment and at 6 and 12 months.</detailed_description>
	<mesh_term>Erythema</mesh_term>
	<mesh_term>Erythema Chronicum Migrans</mesh_term>
	<mesh_term>Glossitis, Benign Migratory</mesh_term>
	<mesh_term>Borrelia Infections</mesh_term>
	<mesh_term>Doxycycline</mesh_term>
	<criteria>presence of erythema migrans &gt;15 years old informed consent pregnancy lactation multiple erythema migrans already treated with antibiotic for this episode of Lyme borreliosis allergy to doxycycline treatment with drugs with known interactions with doxycycline cerebrospinal fluid pleocytosis</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Lyme borreliosis</keyword>
	<keyword>Erythema migrans</keyword>
	<keyword>Doxycycline</keyword>
	<keyword>Subjective symptoms</keyword>
	<keyword>Outcome</keyword>
</DOC>